Neoadjuvant Metformin Added to Systemic Therapy Increases Pathological Complete Response in Breast Cancer: A Cross-sectional Study, Mexico Hospital, Costa Rica

Neoadjuvant Metformin Added to Systemic Therapy Increases Pathological Complete Response in Breast Cancer: A Cross-sectional Study, Mexico Hospital, Costa Rica

Background: Metformin shows anti-proliferative effect on tumor cells. We studied the effect of metformin on achieving complete pathological response (pCR) in breast cancer patients receiving neoadjuvant therapy in a Latin American population. Methods: We conducted a cross-sectional study in Mexico...

Full description

Bibliographic Details
Main Authors: Alicia Van der Laat, Allan Ramos-Esquivel, Denis Ulises Landaverde
Format: Article
Language:English
Published: Kaviani Breast Disease Institute 2018-03-01
Series:Archives of Breast Cancer
Subjects:
Breast cancer
Latin America
Metformin
Neoadjuvant therapy
Online Access:https://archbreastcancer.com/index.php/abc/article/view/163

Similar Items

Similar Items